Related Experiment Video
Updated: Jun 16, 2026
07:20
A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
Published on: January 9, 2018
[Anti-NMDA-receptor encephalitis. An interdisciplinary clinical picture]
1Experimentelle Neurologie und Klinik und Poliklinik für Neurologie, Charité - Universitätsmedizin Berlin, Berlin.
Der Nervenarzt
|February 2, 2010
Summary
Anti-NMDA-receptor encephalitis is an underdiagnosed neurological disorder presenting with psychiatric symptoms. Early diagnosis and immunotherapy are crucial for favorable outcomes in this severe encephalitis.
Area of Science:
- Neurology
- Immunology
- Neuroscience
Background:
- Anti-NMDA-receptor encephalitis is a severe, underdiagnosed neurological condition.
- It presents with diverse symptoms including psychiatric disturbances, seizures, and autonomic dysfunction.
- Often misdiagnosed as drug-induced psychosis, it affects women, men, and children.
Observation:
- Diagnosis relies on clinical presentation, neuroimaging, EEG, CSF analysis, and specific autoantibodies.
- Autoantibodies target the NR1 subunit of NMDA-type glutamate receptors.
- It is essential to rule out anti-NMDA-receptor encephalitis in unexplained encephalitis cases.
Findings:
- Prognosis is generally favorable with prompt diagnosis and treatment.
- Early immunotherapy and tumor removal (if applicable) significantly improve recovery.
- Prolonged intensive care and mechanical ventilation may be required.
Implications:
- Highlights the need for increased awareness among clinicians, especially psychiatrists.
- Emphasizes the importance of early detection and interdisciplinary care.
- Underscores the potential for significant recovery with timely and appropriate management.
More Related Videos
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
Related Concept Videos
01:26Encephalitis ll: Pathophysiology
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
01:19Encephalitis l: Introduction
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
01:25Arboviral Encephalitis
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...